Status:

UNKNOWN

Sleep Disorders in Chronic Kidney Disease Patients

Lead Sponsor:

Assiut University

Conditions:

Chronic Kidney Diseases

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

Brief Summary

1. Asses sleep disorders in CKD patients and those on haemodialysis and related complications ( uncontrolled blood pressure,glomerular filtration rate (GFR) ,proteinuria and psychological disturbance)...

Detailed Description

Sleep disorders are prevalent in patients with chronic kidney disease (CKD) in particular those with end stage renal disease (ESRD). It has been reported that 80% of ESRD patients receiving dialysis r...

Eligibility Criteria

Inclusion

  • patients are between ages 18 and 60 with chronic kidney disease (CKD)( stage III-V) and ESRD Patients on regular haemodialysis \> 6 months.and time of start session of dialysis at 5 pm , thrice weekly .
  • 2\. Random urine albumin/creatinine ratio of 30 mcg/day or greater (protein in the urine) 3. Patients have ability to complete a sleep survey and must be able to swallow tablets.
  • 4\. Patients with compensated heart and liver disease. 5. Not on antipsychotic drugs.

Exclusion

  • Patients with history of psychosis.
  • Patients with decompensated heart or liver disease.
  • Patients with diabetes , autoimmune ,thyroid or neurological disorders.

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05240261

Start Date

May 1 2022

End Date

December 31 2024

Last Update

February 15 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.